Preparation and quality control of ¹⁷⁷Lu-[tris(1,10-phenanthroline) lutetium(III)] complex for therapy

Nucl Med Rev Cent East Eur. 2010;13(2):49-54.

Abstract

The ¹⁷⁷Lu-[tris(1,10-phenanthroline)lutetium(III)] complex (¹⁷⁷Lu-PQ3) was prepared successfully with high radiochemical purity (> 99%). Lu-177 chloride was obtained by thermal neutron flux (4 × 10¹³ n.cm⁻².s⁻¹) of natural Lu₂(NO₃)₃ sample, dissolved in acidic media. The radiochemical yield was checked by measuring the radiochemical purity of the (177)Lu-PQ complex by ITLC (10 mM DTPA, pH = 5, as mobile phase). The final complex solution was injected intravenously into wild-type male rats and bio-distribution of the complex was checked for up to 48 hours. The dose limiting organs were shown to be the reticulu-endothelial system. The bio-distribution of the labelled compounds in tumour-bearing animals is under investigation.

MeSH terms

  • Animals
  • Coordination Complexes / administration & dosage
  • Coordination Complexes / chemistry*
  • Coordination Complexes / pharmacokinetics
  • Coordination Complexes / therapeutic use*
  • Humans
  • Injections, Intravenous
  • Male
  • Organometallic Compounds / administration & dosage
  • Organometallic Compounds / chemistry*
  • Organometallic Compounds / pharmacokinetics
  • Organometallic Compounds / therapeutic use*
  • Phenanthrolines / administration & dosage
  • Phenanthrolines / chemistry*
  • Phenanthrolines / pharmacokinetics
  • Phenanthrolines / therapeutic use*
  • Quality Control
  • Radiochemistry / methods*
  • Radiochemistry / standards
  • Rats
  • Solutions

Substances

  • Coordination Complexes
  • Organometallic Compounds
  • Phenanthrolines
  • Solutions
  • tris(1,10-phenanthroline)lutetium(III)